It has been demonstrated that omeprazole prevents STAT6 from binding to the eotaxin-3 promoter, which in turn inhibits the expression of eotaxin-3 by esophageal cells in eosinophilic esophagitis (EoE) (Cheng et al., 2013). The gene discussed is STAT6; the disease is eosinophilic esophagitis.